Design and Development Challenges in Direct–to–Organ Drug Delivery Platforms

27 September 2022 14:20 - 14:50

Join Cambridge Consultants' Harshal Shah, head of global BioPharma medical technology, as we discuss what are the design and development challenges in direct-to-organ drug delivery platforms:

  • Many new therapies require administration directly to organs, tissues or even tumors.
  • Selection of the delivery method and device technology will depend on accessibility of target site, surrounding anatomy, drug volume, formulation characteristics and frequency of drug administration.
  • The options to consider are: miniature active implants, purpose built delivery systems with embedded visualization and navigation technologies or drug handling and delivery tools designed to be compatible with existing surgical robotic systems.

Harshal Shah, Head of Global BioPharma Commercial, Cambridge Consultants